Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-09, with 31 holding rows worth $388,024,000.

Accession
0001567619-22-019339
Filed
2022-11-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 31 entries on the cover page, a total value of $388,024,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $388,024,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Gilead Sciences,Inc.375558103COM883,106$54,479,000thousands by filing date
BIOGEN INC COM09062X103Stock110,230$29,431,000thousands by filing date
INCYTE CORP COM45337C102Stock418,794$27,908,000thousands by filing date
Bristol-Myers Squibb Company110122108COM353,627$25,139,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM358,700$23,918,000thousands by filing date
Merck & Co.,Inc.58933Y105COM253,159$21,802,000thousands by filing date
Medtronic PlcG5960L103COM269,957$21,799,000thousands by filing date
Elevance Health, Inc.036752103COM46,032$20,910,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock166,080$17,364,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock201,555$15,683,000thousands by filing date
Boston Scientific Corporation101137107COM387,184$14,996,000thousands by filing date
Cigna Corporation125523100COM50,517$14,017,000thousands by filing date
BRUKER CORP116794108COM237,958$12,626,000thousands by filing date
SEAGEN INC81181C104COM84,730$11,594,000thousands by filing date
NUVASIVE INC670704105COM248,649$10,893,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM109,604$9,291,000thousands by filing date
BAXTER INTL INC071813109COM169,028$9,104,000thousands by filing date
QIAGEN NVN72482123SHS NEW204,074$8,424,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock164,223$7,264,000thousands by filing date
BIO RAD LABS INC090572207CL A11,988$5,001,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM115,696$4,531,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM86,692$4,352,000thousands by filing date
CVS Health Corporation126650100COM43,443$4,143,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK68,612$3,193,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock27,077$2,388,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM45,520$1,885,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM89,808$1,731,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,346,904$1,589,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock6,921$1,385,000thousands by filing date
NOVAVAX INC670002401COM NEW56,735$1,033,000thousands by filing date
EMBECTA CORP29082K105COMMON STOCK5,246$151,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-019339this filing2022-11-09acceptance time not in the bulk data set